FDA Reiterates Intention To Regulate Only A Small Portion Of Mobile Medical Apps
This article was originally published in The Gray Sheet
Executive Summary
On the last day of hearings by three House Energy and Commerce subcommittees March 19-21, CDRH Office of Device Evaluation Director Christy Foreman largely reiterated FDA’s previously stated approach to regulating mobile medical apps. Meanwhile, Energy and Commerce Committee Vice Chair Marsha Blackburn, R-Tenn., hinted at legislation on the issue